Al­ice Zhang's 'all-in-hu­man' AI and ge­nomics up­start scores a $98M Se­ries B

Just a few months af­ter Cal­i­for­nia AI and ge­nomics play­er Verge Ge­nomics part­nered with Eli Lil­ly in a $700 mil­lion-plus biobucks deal for 4 neu­ro­log­i­cal pro­grams, the biotech has fin­ished rais­ing its next fi­nanc­ing round — net­ting $98 mil­lion in eq­ui­ty fund­ing with Lil­ly jump­ing on board as a new in­vestor.

The South San Fran­cis­co-based, neu­ro­science-fo­cused com­pa­ny an­nounced the com­ple­tion of the Se­ries B this morn­ing, which was led by Black­Rock-man­aged funds and sup­port­ed by some new big-name in­vestors such as Eli Lil­ly, Mer­ck’s Glob­al Health In­no­va­tion Fund and Vul­can Cap­i­tal. Some ex­ist­ing in­vestors joined in as well, in­clud­ing ALS In­vest­ment Fund and Tao Cap­i­tal Part­ners.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER